This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Rutgers, The State University of New Jersey. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Susan R. Rittling: Innovator in Transgenic Research
Introduction
Susan R. Rittling, an accomplished inventor based in Kingston, NJ, has significantly contributed to the field of biomedical research. With a keen focus on genetics and transgenic technology, her work aims at improving our understanding of osteopontin and its role in various biological processes.
Latest Patents
Rittling holds a patent for an innovative invention titled "Osteopontin knock-out mouse and methods of use thereof." This groundbreaking patent describes a transgenic non-human animal that has been genetically modified to alter the osteopontin gene. The invention facilitates the introduction of a gene encoding an altered osteopontin protein into a host non-human animal. It provides methods for utilizing these transgenic mice to screen for agents that influence osteopontin's cellular modulating activity, potentially paving the way for new therapeutic approaches.
Career Highlights
Susan R. Rittling's professional journey is intrinsically connected to her role at Rutgers, the State University of New Jersey. Here, she has engaged in pioneering research that not only furthers scientific knowledge but also enhances practical applications in medicine and healthcare. Her innovative approach has garnered recognition within academic and scientific communities.
Collaborations
Throughout her career, Rittling has collaborated with esteemed colleagues, including David T. Denhardt and Masaki Noda. Together, they have contributed to advancing research in their field, showcasing the collaborative spirit that drives innovation in scientific discovery.
Conclusion
Susan R. Rittling exemplifies the dedication and creativity characteristic of leading inventors in the biomedical sector. Her contributions, particularly the development of the osteopontin knock-out mouse, represent significant strides in understanding genetic functions and their implications for health. As Rittling continues her work at Rutgers University, her innovations promise to shape the future of genetic research and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile